Challenging the pipeline

This commentary presents a thought experiment seeking to answer the key question: “If you were to put aside all the traditional drug discovery processes and start a new drug discovery program that places the highest priority on human and disease-relevant models throughout the entire process, how cou...

Descripción completa

Detalles Bibliográficos
Autores principales: Loskill, Peter, Hardwick, Rhiannon N., Roth, Adrian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8452595/
https://www.ncbi.nlm.nih.gov/pubmed/34525380
http://dx.doi.org/10.1016/j.stemcr.2021.08.004
_version_ 1784570104056381440
author Loskill, Peter
Hardwick, Rhiannon N.
Roth, Adrian
author_facet Loskill, Peter
Hardwick, Rhiannon N.
Roth, Adrian
author_sort Loskill, Peter
collection PubMed
description This commentary presents a thought experiment seeking to answer the key question: “If you were to put aside all the traditional drug discovery processes and start a new drug discovery program that places the highest priority on human and disease-relevant models throughout the entire process, how could it be done?”
format Online
Article
Text
id pubmed-8452595
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-84525952021-09-27 Challenging the pipeline Loskill, Peter Hardwick, Rhiannon N. Roth, Adrian Stem Cell Reports Commentary This commentary presents a thought experiment seeking to answer the key question: “If you were to put aside all the traditional drug discovery processes and start a new drug discovery program that places the highest priority on human and disease-relevant models throughout the entire process, how could it be done?” Elsevier 2021-09-14 /pmc/articles/PMC8452595/ /pubmed/34525380 http://dx.doi.org/10.1016/j.stemcr.2021.08.004 Text en © 2021 The Author(s) https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Commentary
Loskill, Peter
Hardwick, Rhiannon N.
Roth, Adrian
Challenging the pipeline
title Challenging the pipeline
title_full Challenging the pipeline
title_fullStr Challenging the pipeline
title_full_unstemmed Challenging the pipeline
title_short Challenging the pipeline
title_sort challenging the pipeline
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8452595/
https://www.ncbi.nlm.nih.gov/pubmed/34525380
http://dx.doi.org/10.1016/j.stemcr.2021.08.004
work_keys_str_mv AT loskillpeter challengingthepipeline
AT hardwickrhiannonn challengingthepipeline
AT rothadrian challengingthepipeline

Ejemplares similares